Chromosomal translocation engineering to recapitulate primary events of human cancer

A Forster1, R Pannell, L Drynan

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Insights

Researchers developed novel mouse models to mimic human chromosomal translocations, crucial for understanding cancer development and testing new therapies. These advanced models enable precise study of gene fusions and their role in various cancers.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Chromosomal translocations are key drivers in numerous human cancers, including leukemias, sarcomas, and epithelial tumors.
  • Accurate mouse models are essential for dissecting cancer etiology and advancing preclinical therapeutic development.

Purpose of the Study:

  • To develop novel mouse models that accurately mimic human chromosomal translocations.
  • To provide a framework for studying the role of specific translocations in cancer development and for evaluating therapeutic strategies.

Main Methods:

  • Utilized homologous recombination in mouse embryonic stem (ES) cells to engineer three distinct translocation models.
  • Developed a "knockin" method for creating fusion genes characteristic of human leukemias and sarcomas.
  • Created conditional translocation mimics: "translocator mice" using Cre-loxP recombination for reciprocal translocations and "invertor mice" for incompatible gene orientations.

Main Results:

  • Successfully generated MLL-mediated neoplasias using the translocator model.
  • Demonstrated the utility of the invertor method in generating EWS-ERG-mediated cancer.
  • Validated the ability of these models to replicate human chromosomal translocation scenarios.

Conclusions:

  • The developed knockin, translocator, and invertor mouse models effectively mimic human chromosomal translocations.
  • These models offer a powerful platform for investigating the mechanisms of translocation-driven cancers.
  • They facilitate the design and preclinical evaluation of targeted therapies for human cancers caused by chromosomal abnormalities.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Gene Conversion02:08

Gene Conversion

Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...